Staff Clinicians (Physicians)
Clinical Trials Program
Vaccine Research Center
The National Institute of Allergy and Infectious Diseases (NIAID), one of the largest institutes of the National Institutes of Health (NIH) and part of the Department of Health and Human Services (HHS), conducts and supports a global program of research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. The Clinical Trials Program (CTP) in the Vaccine Research Center (VRC) within NIAID is soliciting applications for two staff clinicians (physicians) to serve as principal or associate investigators of Phase 1 trials evaluating vaccines or monoclonal antibodies against a variety of infectious diseases.
VRC conducts research that facilitates the development of effective vaccines and monoclonal antibodies for the prevention of infectious diseases, such as HIV, influenza, malaria, Zika, Ebola, and SARS-CoV-2.
CTP includes a team of clinicians, protocol specialists, research nurses, study coordinators, data specialists, and other support staff. CTP conducts proof-of-concept, Phase 1 clinical research studies to assess the safety and immunogenicity of first-in-human vaccines and monoclonal antibodies. CTP is composed of approximately 50 people and initiates 3 to 5 clinical trials per year in the NIH Clinical Center. CTP also maintains and oversees collaborations and contracts with academic institutions, biotechnology and pharmaceutical companies, and nonprofit organizations that evaluate VRC products.
The staff clinician will work closely with the CTP chief and other VRC staff in clinical trial design, protocol development, clinical trial operations, and oversight.
Specific responsibilities of the position include the following:
• Design and implement innovative clinical research for VRC
• Serve as an associate or principal investigator for VRC clinical protocols and trials
• Conduct and provide oversight for vaccine and monoclonal antibody clinical trials
• Design, conduct, and analyze data from clinical and translational vaccine immunology research studies
• Participate in a variety of meetings with VRC clinical development teams
• Present VRC research findings publicly (domestically and internationally)
• Develop and write manuscripts of VRC clinical research findings
• Participate as a team member, co-chair, or chair of domestic and international protocol/clinical trial teams involving VRC study products
• Serve as a member on NIH and external committees and boards as assigned by VRC
• Mentor junior scientists and clinicians, including clinical fellows
Qualifications
Required
• A doctoral degree (M.D. or D.O.) and an active, unrestricted medical license in the United States
• Qualify for credentialing to practice as a staff physician in the NIH Clinical Center
• Excellent written and verbal communication skills
Preferred
• Board certification in infectious diseases or allergy and immunology (other internal medicine specialty training will be considered)
The ideal candidate will have clinical experience in infectious diseases and clinical trial research of vaccines. Research experience in virology, and specifically in respiratory virus infections, is a plus.
Salary is commensurate with experience and accomplishments.
To Apply
Applications will be reviewed beginning May 29, 2024 and will be accepted until the position is filled. Interested candidates should email the following to [email protected]
• Curriculum vitae
• A letter describing your interest in the position and long-term goals
Appointees may be U.S. citizens, legal permanent residents, or non-U.S. citizens who are eligible for a valid work authorization. Applications from women, persons from underrepresented groups, and persons with disabilities are strongly encouraged. Applications will be accepted until the position is filled. This position is subject to a background check.
Visit NIAID Careers for more information about working in NIAID’s dynamic atmosphere.
HHS, NIH, and NIAID are equal opportunity employers dedicated to diversity, equity, inclusion, and accessibility.